Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…

Eli Lilly

Fresh off a 9% quarterly sales hike, Lilly sees new launches driving solid growth through 2020

Diabetes sales rocket toward $60B, with Novo and Lilly's GLP-1s first in line for growth

American Idol star joins Eli Lilly's diabetes kids camp efforts

UPDATED: Lilly, BI narrowly escape with panel backing for Jardiance CV death claim

Lilly's Trulicity joins pay-for-performance trend with Harvard Pilgrim deal

Lilly execs: Net price pressures not a concern for new diabetes meds

Reduce CV events, check. Now, Lilly, BI's Jardiance shows it can cut kidney disease risk, too

Novo Nordisk's diabetes med Victoza chops cardiovascular risks by 13%

Merck's Lantus biosim MK-1293 gets closer to U.S. nod with new PhIII data